Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
SGX:T14
RESEARCH TOOLSreports
Holding SG:T14?
Track your performance easily
T14 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.66 - $2.66
Previous Close$2.36
Volume17.60K
Average Volume (3M)118.25K
Market Cap
$4.14B
Enterprise Value$3.79B
Total Cash (Recent Filing)¥2.88B
Total Debt (Recent Filing)¥257.91M
Price to Earnings (P/E)14.0
Beta0.29
Next Earnings
Mar 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 02, 2024Dividend Yield7.43%
Share Statistics
EPS (TTM)0.17
Shares OutstandingN/A
10 Day Avg. Volume90,660
30 Day Avg. Volume118,245
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S News
PremiumCompany Announcements
Tianjin Pharmaceutical Announces A-Share Adjustments
PremiumCompany Announcements
Tianjin Pharmaceutical Completes Key Milestone in Incentive SchemePremiumCompany Announcements
Tianjin Pharmaceutical Announces Corporate Amendments
PremiumCompany Announcements
Tianjin Pharmaceutical Announces Sixth A-Share RepurchasePremiumCompany Announcements
Tianjin Pharma Group Proposes Shareholder-Approved Amendments
PremiumCompany Announcements
Tianjin Pharmaceutical Adjusts A-Share Repurchase Strategy
PremiumCompany Announcements
Tianjin Pharmaceutical Adjusts Share Repurchase and Cancellation
PremiumCompany Announcements
Tianjin Pharma Advances with New Equity Joint VentureOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
T14 FAQ
What was Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price range in the past 12 months?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S lowest share price was $1.66 and its highest was $2.66 in the past 12 months.
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s market cap?
Currently, no data Available
When is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date is Mar 31, 2025 which is in 128 days.
How were Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s earnings last quarter?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S released its earnings results on Oct 30, 2024. The company reported $0.026 earnings per share for the quarter, beating the consensus estimate of N/A by $0.026.
Is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S overvalued?
According to Wall Street analysts Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price is currently Overvalued.
Does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pay dividends?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays a Annually dividend of $0.18 which represents an annual dividend yield of 7.43%. See more information on Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S dividends here
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S have?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding.
What happened to Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price movement after its last earnings report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S reported an EPS of $0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.646%.
Which hedge fund is a major shareholder of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S?
Currently, no hedge funds are holding shares in SG:T14
---
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Stock Smart Score
Company Description
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Zhong Xin Pharmaceutical Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
---
Technical Analysis
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
―
Advanced Blockchain AG
―
---